SunGen Pharma receives seventh ANDA approval from US FDA

This article was originally published here

The seventh approved ANDA is for Fosapreptant for Injection 150mg/vial. This drug product is used for treatment of cyclic vomiting syndrome and late-stage chemotherapy induced vomiting. This is

The post SunGen Pharma receives seventh ANDA approval from US FDA appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply